Daniel Sumarriva/LinkedIn
Jun 2, 2025, 08:11
Daniel Sumarriva: An Unforgettable Night at ASCO25 with SAGA Diagnostics
Daniel Sumarriva, Executive Medical Director at SAGA Diagnostics, posted on LinkedIn:
“An unforgettable night at ASCO25 with SAGA Diagnostics.
Last evening, I had the privilege of presenting on the power of high-sensitivity ctDNA detection using our Pathlight MRD platform and engaging in a dynamic expert panel discussion alongside thought leaders in the space.
Together, we explored the future of molecular residual disease (MRD) detection and its clinical impact on personalized cancer care. The insightful dialogue and passionate exchange of ideas reaffirmed our shared commitment to advancing precision oncology.
A special thanks to everyone who joined us — the energy, questions, and connections made the night truly meaningful.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 00:35
Jun 3, 2025, 16:39